Grants and IIT Program

The IIT program at Haemonetics supports original, independent, investigator-initiated research aimed at advancing science and clinical care. The company reviews unsolicited requests for research support, which may include devices, disposable, reagents, software and/or funding.

Areas of high research interest include, but are not limited to:

• Personalized treatment algorithms for high bleeding risk conditions, such as trauma, cardiovascular surgery, liver transplant, post-partum hemorrhage etc.
• Tailored thromboprophylaxis (i.e., antiplatelet and anticoagulant therapies) in cardiovascular patients (e.g., Coronary Artery Disease, Peripheral Artery Disease)
• Coagulation profiles and clinical outcomes in patient populations at increased risk for thrombotic complications (e.g., patients admitted to ICU)
• Clinical and health-economic benefits of device assisted vascular closure

Review Criteria

Decisions are based upon scientific merit, proposal’s clinical significance, feasibility and likelihood of success given the Principal Investigator’s track record and research environment, as well as alignment with Haemonetics’ areas of research interest and availability of resources.

Submission Process

Only full protocol submissions will be reviewed by the Scientific Review Committee. However, if you wish to gain insights regarding the company’s interest in your research idea, you can submit a concept form for review by the Medical Director.

The link to the Haemonetics investigator-initiated trial grant request form can be found here: https://Haemonetics.medcompli.com. Once you create a grant requester login using your email, then pick “Make a request” from the main page, and select “Haemonetics Investigator-initiated trial proposal” from the drop-down list.  If you have any questions about the form, or have questions you would like to ask before submitting a request, you can reach out to the Medical Affairs team at Haemoneticsgrantsprogram@haemonetics.com. 

To submit a protocol for consideration, please send the protocol (see instructions below) along with any supporting documentation via the “Haemonetics Investigator-initiated trial proposal” form process detailed above.

• CV or biosketch of the Principal Investigator
• Research Plan (in Arial, font size ≥ 11, 1 inch margin on all sides) consisting of: 
  • Introduction – Brief description of problem, hypotheses and aims (1/2 page max) 
  • Approach – Concise overview of the research methods including statistical analysis plan (2 pages max) 
  • Timeline and Budget – Can be in a chart format  (1/2 page max) 
  • References (no page limitation) 

If you wish to do so, please email the program administrator for a template.

At Haemonetics, we are committed to advancing global medical knowledge and fostering innovation. Through our educational grants, we proudly support initiatives that empower healthcare professionals with cutting-edge education, contribute to the development of transformative products and services, and advocate for patient care improvements worldwide. By investing in these programs, we help shape the future of healthcare and make a lasting impact on patient outcomes.

Eligibility Criteria

To ensure that grants are awarded ethically and responsibly, we require that applicants meet the following eligibility criteria:

1. Educational Focus: Programs must deliver genuine educational value to healthcare professionals and focus on medical, scientific, or patient-care topics that improve healthcare quality and patient outcomes.
2. Independence: Educational activities should be organized and controlled by the requesting organization. Haemonetics will have no influence over program content, speakers, or attendees.
3. Eligible Program Types: Grant funding may support medical education and training for Healthcare Professionals, patient advocacy efforts, health outcomes improvement programs, medical conferences, workshops, or symposia that align with healthcare industry standards.
4. Healthcare Professional Audience: Programs should target healthcare professionals, medical students, or trainees, aiming to advance their knowledge and clinical skills.
5. Transparency of Purpose and Use: Requests must include a detailed description of the program, objectives, scope, and budget. Grant recipients must provide documentation on fund usage and ensure compliance with the grant’s intended purpose.
6. No Promotion of Company Products: Educational activities should be independent of any product endorsements, promotional materials, or advertising related to Haemonetics products or services.
7. Fair Market Value: Grant amounts must be reasonable and reflect fair market value for the educational services provided, ensuring funding is appropriate and not excessive.
8. Adherence to Legal and Regulatory Standards: All grant-funded activities and recipients must comply with applicable laws and regulations, including anti-kickback and conflict of interest standards.

How to Apply
To request an educational grant, please submit a complete application detailing the program’s educational objectives, audience, and budget, along with supporting documentation here. All applications will be reviewed in line with these criteria to ensure alignment with Haemonetics commitment to advancing healthcare knowledge and patient care.

If you wish to proceed with the application, Haemonetics uses an external website to handle all requests. To access the system please create a profile. You can find the guidelines for the request process here. 

Privacy Statement

Your privacy is important to us. We will only use the information provided in this form to evaluate your eligibility for an educational grant. For details on how we handle your information, please review our Privacy Statement.

Contact Us

If you have any questions about the application process or eligibility, please contact our Global Compliance Team at HCPCompliance@haemonetics.com.

We appreciate your interest in partnering with us to advance healthcare and community welfare initiatives worldwide. Together, we can make a positive difference.